GridAI Technologies Corp.GRDX

$5.40+0.45 (+9.09%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$24M

Micro-cap

-79%

2016 — today

10-Year Price

-100%

2016 — today

52-Week Range

$1.09$6.80

Current $5.40· 75%

GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.

Valuation in context

P/E ratio

-1.1

N/A

Not meaningful — company is unprofitable

P/B ratio

0.9

Below average

Below the 10-year average

FCF Yield

-27.8%

Around average

Around the 10-year average

Free · No credit card needed

Get alerted when GRDX is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.